Ghosts in the Machine: Jonathan B. Koea MD; FRACS. Department of Surgery Auckland Hospital Auckland New Zealand

Similar documents
Follow up The way ahead. John Griffith

MANAGEMENT OF COLORECTAL METASTASES. Robert Warren, MD. The Postgraduate Course in General Surgery March 22, /22/2011

Faster Cancer Treatment Indicators: Use cases

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES

ADJUVANT CHEMOTHERAPY...

COLON AND RECTAL CANCER

Manchester Cancer Colorectal Pathway Board: Guidelines for management of colorectal hepatic metastases

Diagnosed with Metastatic Colorectal Cancer?

Surgical Management of Advanced Stage Colon Cancer. Nathan Huber, MD 6/11/14

Colorectal Liver Metastases Metachronous

COLON AND RECTAL CANCER

Treatment strategy of metastatic rectal cancer

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

National Cancer Programme. Work Plan 2015/16

Treatment of Colorectal Liver Metastases State of the Art

Radiotherapy for Rectal Cancer. Kevin Palumbo Adelaide Radiotherapy Centre

OFCCR CLINICAL DIAGNOSIS AND TREATMENT FORM

COLORECTAL CARCINOMA

State of the art management of Colorectal Liver Metastasis: an interplay of Chemotherapy and Surgical options

BOWEL CANCER. Causes of bowel cancer

Trattamento chirurgico delle lesioni epatiche secondarie difficili. Adelmo Antonucci Chirurgia Oncologica e Epato-bilio-pancreatica

Cancer of Unknown Primary (CUP) Protocol

Structured Follow-Up after Colorectal Cancer Resection: Overrated. R. Taylor Ripley University of Colorado Grand Rounds April 23, 2007

CT PET SCANNING for GIT Malignancies A clinician s perspective

Management of colorectal cancer liver metastases

Clinical guideline Published: 1 November 2011 nice.org.uk/guidance/cg131

How to deal with synchronous primary and liver metastases

Bowel Cancer Quality Improvement Report

Bowel Cancer in England and Wales A summary report about the management and outcomes of people with bowel cancer

National Cancer Programme. Work Plan 2014/15

Current Treatment of Colorectal Metastases. Dr. Thavanathan Surgical Grand Rounds February 1, 2005

Colon Cancer Liver Metastases: Liver-Directed Therapy

Causation Issues. Delay in Diagnosis of Cancer Cases. Prof Pat Price Imperial College London

COLORECTAL CANCER FAISALGHANISIDDIQUI MBBS; FCPS; PGDIP-BIOETHICS; MCPS-HPE

IMAGING GUIDELINES - COLORECTAL CANCER

COLORECTAL CANCER 44

Bladder tumour resection (TURBT): procedure-specific information

Management of Stage IV Colorectal Cancer: Expanding the Horizon

Primary tumor with synchronous metastases

Watching and waiting : what it means for patients. Dr Christian Aldridge Consultant Dermatologist Cwm Taf NHS Trust

By: Tania Cortas, MD Arizona Oncology 03/10/2015

LIVER SURGERY 2. Case 1. Med 5 Refresher Course (Surgery) 2013/14. Dr Sunny Cheung

Gastric and Colon Cancer. Dr. Andres Wiernik 2017

Better Outcomes for Lung Cancer in Family Practice. AProf Jeff Garrett Respiratory Physician

The Urology One-Stop Clinic

CASE STUDIES IN COLORECTAL CANCER: A ROUNDTABLE DISCUSSION

Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 5

Multidisciplinary Treatment Strategies for Primary and Metastatic Liver Cancers

Patient Presentation. 32 y.o. female complains of lower abdominal mass CEA = 433, CA125 = 201

Audit Report. Colorectal Cancer Quality Performance Indicators. Patients diagnosed April 2014 March Published: July 2016

Midland Region All Boards Development Days. Midland Cancer Network. 15, 16 October, 2015

Staging Colorectal Cancer

Kelly D. Post RN, BSN, OCN Gastrointestinal Nurse Navigator Advocate Christ Medical Center, Cancer Institute April 5, 2014

New Zealand Palliative Care: A Working Definition.

Colorectal peritoneal metastases and IMPACT

Techniques to Improve Resectability of Colorectal Liver Metastases Ching-Wei D. Tzeng, M.D.

The Cambridge Breast Unit

Audit Report. Colorectal Cancer Quality Performance Indicators. Patients diagnosed April 2016 March Published: March 2018

Integration of palliative care into oncology

Role of Patient Navigation and A Team Approach to Coordinated Care June 13, 2016

Caring for a Patient with Colorectal Cancer. Objectives. Poll question. UNC Cancer Network Presented on 10/15/18. For Educational Use Only 1

Colorectal Cancer Care

Unknown Primary Service for patients at Chesterfield Royal Hospital

Treatment of Locally Advanced Rectal Cancer: Current Concepts

Colorectal Cancer. Mark Chapman. MA MS FRCS EBSQ(coloproct) 21 st March 2018 Consultant Coloproctologist

Blakely T, Tobias M et al. Tracking disparity: Trends in ethnic and socioeconomic inequalities in mortality, Wellington: Ministry of

RECTAL CANCER CLINICAL CASE PRESENTATION

South West Regional Cancer Program. Cancer Plan

BOWEL CANCER. Cancer information.

Low-dose capecitabine (Xeloda) for treatment for gastrointestinal cancer

Intended for use by Clinicians and Health Care Providers involved in the Management or Referral of adult patients with pancreatic

THE NEW ZEALAND MEDICAL JOURNAL

Colorectal Pathway Board (Clinical Subgroup): Imaging Guidelines September 2015

State of the Art: Colorectal Cancer Liver Metastasis Dr. Iain Tan

Behandeling van colorectale levermetastasen. Rol van beeldvorming van de lever bij colorectaal carcinoom

Physician Follow-Up and Guideline Adherence in Post- Treatment Surveillance of Colorectal Cancer

Registrar Palliative Medicine

Maria Parham Cancer Center Henderson NC Annual Report 2013

Bowel Cancer Information Leaflet THE DIGESTIVE SYSTEM

NICE Quality Standards and COF

Is it possible to cure patients with liver metastases? Taghizadeh Ali MD Oncologist, MUMS

COLORECTAL CANCER CASES

Colon, or Colorectal, Cancer Information

Screening and Detection in Cancer Survivors. Jose W. Avitia, MD Oncology/Hematology

Afternoon Session Cases

The NIHCE guidelines for the management of colorectal cancer

Colorectal cancer starts in the colon or rectum.

Navigators Lead the Way

Colorectal Cancer at the MemorialCare Todd Cancer Institute at Long Beach Memorial

UNDERSTANDING YOUR DIAGNOSIS. Helpful reading on colorectal cancer and colorectal adenomas

Transforming Cancer Services for London

Esophageal cancer. What is esophageal cancer? Esophageal cancer is a disease in which malignant (cancer) cells form in the tissues of the esophagus.

How to integrate surgery in the treatment of patients with liver-only metastatic disease

This brochure has been created for employers. It isn t intended for use by policy members.

Resection of liver limited resectable metastases Upfront, neoadjuvant and repeat hepatectomy

Cancer , The Patient Education Institute, Inc. ocf80101 Last reviewed: 06/08/2016 1

Introduction. Case Report

A Special Project of the Auckland Breast Cancer Study Group. - prepared by Wendy Dykes (Ak. Breast Cancer Register Data Manager)

Colorectal Cancer and FDG PET/CT

Transcription:

Ghosts in the Machine: Patient Journeys Through Cancer Treatment Jonathan B. Koea MD; FRACS. Department of Surgery Auckland Hospital Auckland New Zealand

Age-Standardised Cancer Incidence (100,000 population) 500 400 300 100 80 60 40 20 Maori male Non-Maori male Maori female Non-Maori female All Breast Lung Prostate CRC HCC Cervix Ovary Lancet Oncol 2008;9:473

Age-Standardised Cancer Mortality (100,000 population) 300 200 100 Maori male Non-Maori male Maori female Non-Maori female 80 60 40 20 All Breast Lung Prostate CRC HCC Cervix Ovary Lancet Oncol 2008;9:473

Age-Standardised CRC Incidence (100,000 population) 60 50 Maori male Non-Maori male Maori female Non-Maori female 40 30 20 10 1988 2004 Aust NZ J Public Health 2006;30:64

CRC: Presentation Local Symptoms Obstruction Perforation

Surgery for Colorectal Cancer

Natural History of Cancer

Colorectal Cancer in 1975 40 year old female Colectomy for cancer Synchronous metastasis noted 6 weeks 5-FU 30 June 1975 (R) hepatectomy 1 month hospital stay 24 mths 5-FU post-operatively Alive & well @ 31 years

Treatment Summary Investigations: Barium enema Hospital stay: Colectomy 14 days Hepatectomy 32 days Blood tests: 42 Outpatient appointments: 4 in 2 years 30 chemotherapy appointments

What About 2008? 58 yr old female from Northland living in South Island No past medical history 3 weeks PR bleeding Reviewed by GP: 05/04/2008» Raised CEA» Mildly anaemic Hb 100 g/l» Abnormal liver function tests Referred for specialist assessment and colonoscopy

Locally Advanced Rectal Cancer

Synchronous Hepatic Metastases

Clinical Review Locally advanced node positive rectal cancer Seven synchronous liver metastases Outcome:» Metallic rectal stent» Palliative radiation therapy

Transfers to Auckland for radiation therapy 40 Gray administered over 4 weeks Stent falls out Reassessed: colorectal and hepatobiliary surgery Treatment intent revised: active therapy

Treatment of Rectal Primary 10/07/2008: Anterior resection No covering stoma 7 day hospital stay No complications Final Pathology: Low grade adenocarcinoma T3N1M1

Rectal Cancer Resection Dukes Stage Local Recurrence Systemic Recurrence A 2% 8% B 4% 18% C 7.5% 37% Nodes Number Local Systemic Patients Recurrence Recurrence 0 300 6 (2%) 33 (11%) 1-4 135 7 (5%) 30 (22%) 5-8 22 0 8 (36%) >8 13 3 (23%) 7 (53%) Dis Colon Rectum 2004;47:1145

Treatment of Metastatic Disease Repeat CT scan MDM review 08/08/2008 begins neoadjuvant chemotherapy» Oral capcitabine» Intravenous oxaliplatin First week of therapy in Auckland Subsequently transfers to Whangarei Outpatient chemotherapy 08/09/2008-09/01/2009

Liver Resection for Colorectal Cancer probability of survival 1.0 0.8 0.6 0.4 0.2 multiple bilateral (n = 82) multiple unilateral (n = 114) solitary (n = 294) patients at risk 45 88 25 p = 0.24 15 9 22 0.0 0 2 4 6 8 10 Lancet 1994;343:1405 Years from R 0 -liver resection

R0 versus R1 Resection probability of survival 1.0 0.8 0.6 0.4 0.2 15 months 44 months 41.4% (158) R0-resection (n = 490) R1/2-resection (n = 114) disease-free survival p = 0.0000001 28.3% (46) 0.0 0 2 4 6 8 10 Lancet 1994;343:1405 34.7% (128) 26.5% (44) v s Years from liver resection

Extrahepatic vs No Extrahepatic Tumour 1.0 probability of survival 0.8 0.6 0.4 0.2 Extrahepatic tumor (n = 66) No extrahepatic tumor (n = 424) patients at risk 146 45 12 p < 0.00002 1 0.0 0 2 4 6 8 10 Lancet 1994;343:1405 Years from R 0 -liver resection

Surgical Follow up 05/09/2008: Initial assessment 28/11/2008: Review 03/12/2008: MDM review 23/01/2009: Review at end chemotherapy» Decision: requires portal vein embolization» Referred to radiology 17/03/2009: Follow up no word from radiology 26/03/2009: Portal vein embolization

Portal Vein Embolization

Portal Vein Embolization Pre 18% Post 31%

Hepatectomy 27/04/2009: Extended right hepatectomy 8 day hospital stay No complications 7 metastases in specimen Closest margin 4 mm

Follow Up 29/05/2009: Well, CEA normal 07/08/2009: Well, Follow up CT scan arranged Further appointment in 6 months

Treatment Summary Duration 61 weeks Procedures: 6 (colonoscopy x 2, ERT x 15, sigmoidoscopy, anterior resection, portal vein embolization, liver resection) Total Hospital Stay: 29 days Outpatient visits: 16 Chemotherapy 30 appointments for infusional therapy CT/MRI Scans: 8 Blood tests: 74 Travel to Auckland Hospital: 13 + 15 ERT

Anxieties / Uncertainties Palliative to therapeutic? Will chemotherapy be effective? Two major operations in 1 year? Will embolization work? Wait times:» Surgery within 6 weeks of booking» Portal vein embolization in 7 weeks booking What does the future hold?

But how do you survive cancer? That s the part no one gives you any advice on. What does it mean? Once you finish your treatment, the doctors say, You re cured, so go off and live. Happy trails. But there is no in place to help you to deal with the emotional ramifications of trying to return to the world after being in the battle for your existence. I was a bum. I played golf every day. I water-skied, I drank beer, and I lay on the sofa and channel-surfed. I went to Chuy s for Tex-Mex, and violated every support system rule of my training diet. Its Not About the Bike p186, 196

The Future? 3 6 monthly OPC review 6 monthly CT scans for 2 years then annually 3 monthly CEA Further chemotherapy Further surgery Ablative procedures (SIRT, RFA)

What do Maori Want? Maori providers; empathy with whanau, practical assistance Competence, warmth, honesty, respect, care Providers that meet cultural needs halfway Whanau involvement & proximity Assertive navigation Access to Rongoa Cancer Screening NZMJ 2008;121;1279

What do Non-Maori Want? Full & frank discussion regarding prognosis & options Prognostic information can be upsetting but still desired Retain family structure and unit Information on life effects & treatment effects Trust their caregivers (faith) Have some hope for life J Clin Oncol 2007;25:5275, J Clin Oncol 2006;24:5265, Support Care Cancer 2004;12:663, BMJ 2000;320:909

What Support is Available? Cancer Society of New Zealand Maori health providers Nursing and medical staff Nurse Practitioners Mainstream services Navigators Hospice

Cancer Society of New Zealand Operates regionally similar to Iwi based structure Salaried staff and strong reliance on volunteers Offer accommodation, transport assistance, education, support Engaged in funding oncology research Increasing national advocacy role Stated aim to contribute to care of Maori and Pacific

Maori Providers www.maorihealth.govt.nz

MAPAS Intake. 120 100 80 60 40 20 Intake Maori Graduated 0 1972-76 1977-81 1982-86 1987-91 1992-96 1997-01 2002-2006

NZ Registered Medical Practitioners Ethnicity % Male % Female % Total European 66.5 33.5 72.5 Maori 62.1 37.9 2.3 Pacific 69.5 30.5 1.1 Asian 79.1 28.1 4.5 NZHIS Medical Practitioner Workforce Survey 2000

Registrars by Ethnicity Ethnicity % Male % Female % Total European 58.7 41.3 65.8 Maori 55.0 45.0 3.3 Pacific 70.3 29.7 2.2 Asian 69.3 30.7 6.1 NZHIS Medical Practitioner Workforce Survey 2000

Nurse Practitioners Hospital based Roving brief Preadmission patient contact Orchestration of admission issues (clinics, accommodation) Familiar with treatment algorithms (advocacy) Post procedure follow up (phone clinic) Some contact with primary care providers

Mainstream Organizations Bound by legislative Treaty obligations Constrained by size and complexity Institutional inertia Maori health often devolved to small numbers Maori staff Services now developing provider role as well as advisor role Mass education often required

Patient Navigators First implemented 1990 16 published studies:» 7% increase screening» 9% increase in follow up» no evidence for improving diagnosis, access outcomes» no data patient satisfaction Main tasks: finance, transportation, end of life, dependent care, scheduling of appointments 2008 NCA began Navigator Training Program J Gen Intern Med 2009;24:211, J Natl Med Ass 2008;100:1290, Cancer 2008;113:1999, Cancer 2008;113:426

Job Description Clinically confident Knowledge of hospital workings and structures Strong links with primary care providers Comfortable in primary, secondary and tertiary care facilities Outstanding people skills Culturally competent Sound knowledge of standards of cancer care

Summary Cancer care evolved rapidly in the last 10 years Management is now multidisciplinary Treatment has become complex and prolonged Survival and cure rates are improving Cancer has assumed status of a chronic disease Physical, emotional and temporal costs to patient & Whanau just being recognised